marijuana stocks

Insys Therapeutics misses 2Q profit forecasts

Insys Therapeutics posts 2Q profit of $7.3 million, result misses forecasts

 CHANDLER, Ariz. (AP) _ Insys Therapeutics Inc. (INSY) on Thursday reported second-quarter net income of $7.3 million.

The Chandler, Arizona-based company said it had net income of 10 cents per share. Earnings, adjusted for stock option expense and pretax expenses, came to 21 cents per share.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 23 cents per share.

The specialty pharmaceutical company posted revenue of $77.6 million in the period.

Insys Therapeutics shares have more than doubled since the beginning of the year. The stock has more than tripled in the last 12 months.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tilray Brands, Inc. (TLRY) Wins Tender to Supply Luxembourg with Medical Cannabis

Tilray Medical Wins Tender to Supply Luxembourg with Medical Cannabis Tilray Brands,…

Tetra Bio-Pharma Inc. (TBPMF) Concludes its First Sale of Rx Princeps(TM) Inhalation Device

Tetra Bio-Pharma Concludes its First Sale of Rx Princeps(TM) Inhalation Device Tetra…

Hemp, Inc. (HEMP) CEO Bruce Perlowin to Speak at Carolina Hemp Festival in North Carolina

Hemp, Inc. CEO Bruce Perlowin to Speak at Carolina Hemp Festival in…

Verano Holdings Corp. (VRNOF) Launches BITS, Company’s New Low-Dose, High-Function Edibles

Verano Launches BITS, Company’s New Low-Dose, High-Function Edibles Verano Holdings Corp. (CSE:…